Cinda Biotech (01801.HK) grants 3,371 share options and 9551 restricted shares
Gelonghui, May 3, 丨 Cinda Biotech (01801.HK) announced that on May 3, 2024, the company granted 3,371 share purchase rights to independent non-executive director Chen Shuyun in accordance with the terms of the initial public offering after-sales employee share ownership plan, subject to Chen's acceptance. The board of directors announced that on May 3, 2024, the company granted 9551 restricted shares to Chen Shuyun in accordance with the 2020 Restricted Shares Plan, subject to Chen's acceptance and approval by independent shareholders at the Annual General Meeting of Shareholders.
Cinda Biotech (01801): Zhang Qian was appointed as Executive Director and Strategy Committee Member
Cinda Biotech (01801) announced that since May 3, 2024, Mr. Chen Shuyun has been appointed as an independent non-...
Riel Group (06639.HK) spent HK$123,000 to buy back 19,000 shares on May 3
Glonghui on May 3 | Riel Group (06639.HK) announced that it spent HK$123,000 to repurchase 19,000 shares on May 3.
Express News | Meituan bought back 1.861 million shares on the 3rd, costing about HK$215 million
Meituan-W (03690.HK) spent HK$215 million to buy back 1.861 million shares on May 3
Gelonghui on May 3 | Meituan-W (03690.HK) announced that it spent HK$215 million to buy back 1,861 million shares on May 3.
XTEP INT'L To Go Ex-Dividend On May 7th, 2024 With 0.08 HKD Dividend Per Share
May 3rd - $XTEP INT'L(01368.HK)$ is trading ex-dividend on May 7th, 2024. Shareholders of record on May 8th, 2024 will receive 0.08 HKD dividend per share on June 28th, 2024. The ex-dividend date